About this trial
The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI.
To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.
Eligibility criteria
Qualifiers
Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09).
For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
For adolescents: assent to participate
For adults: Ability to understand and the willingness to sign a written informed consent
Disqualifiers
Patients with Glycogen storage disease unspecified
Patients not meeting inclusion criteria
Patients unable to provide consent
Patients who decline to be in the study
Trial design
Treatments tested in this trial
- Lactate Meter
- Accu Chek
Treatment groups
Sponsors and collaborators
Connecticut Children's Medical Center
Lead sponsor
Global Center for Glycogen Storage Disease held at the Jewish Community Foundation
Collaborator